Patient Empowerment Program: A Rare Disease Podcast
by n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen)
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇦🇺AU · Life Sciences#1765K to 30K
- 🇧🇷BR · Life Sciences#9410K to 30K
- 🇯🇵JP · Life Sciences#1031K to 10K
- 🇭🇰HK · Life Sciences#115500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
8.3K to 37K🎙 ~2x weekly·93 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
17K to 73K🇦🇺41%🇧🇷41%🇯🇵14%+1 more - Active Followers
Loyal subscribers who consistently listen
5.0K to 22K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 16 epsHosts
Recent guests
Recent episodes
Miracles of Science: Antisense Technology
Jul 15, 2026
34m 57s
The Personal Rare Disease Journey Behind CNBC Cures with Becky Quick
Jul 1, 2026
1h 09m 32s
Patient Story: Understanding ALS with Bill O'Sullivan and Neil Shneider, M.D., Ph.D.
Jun 17, 2026
52m 47s
Miracles of Science #3: RNA World Part 3
Jun 3, 2026
36m 18s
Miracles of Science #3: RNA World Part 2
May 27, 2026
27m 49s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/15/26 | Antisense TechnologyDrug Discovery+3 | — | n-Lorem FoundationIonis | — | Antisense TechnologyDrug Discovery+5 | Hongene | 34m 57s | ||
| 7/1/26 | rare diseasepatient empowerment+4 | Becky Quick | CNBC CuresCNBC+1 | United States | rare diseaseSYNGAP1+7 | Chemgenes | 1h 09m 32s | ||
| 6/17/26 | ALSgenetic testing+3 | Bill O'SullivanNeil Shneider, M.D., Ph.D. | n-Lorem Foundation | — | ALSCHCHD10 mutation+5 | ChemGenes | 52m 47s | ||
| 6/3/26 | RNA biologycellular function+3 | — | n-Lorem Foundation | — | RNAribosomal RNA+6 | — | 36m 18s | ||
| 5/27/26 | RNA biologyantisense therapies+3 | — | n-Lorem Foundation | — | RNApre-RNAs+3 | ChemGenes | 27m 49s | ||
| 5/20/26 | RNA biologygenetic medicine+4 | — | Spinrazan-Lorem Foundation+1 | — | RNA Worldgenetic therapies+3 | — | 33m 38s | ||
| 5/6/26 | rare diseasediagnosis journey+4 | Callan Pleasant | n-LoremHNRNPH2 | — | HNRNPH2rare disease+4 | — | 1h 04m 36s | ||
| 4/22/26 | nano-rare diseasefamily dynamics+3 | Oliver Glass | n-LoremDYRK1A | — | DYRK1A syndromerare disease+3 | — | 49m 32s | ||
| 4/8/26 | nano-rare diseasefamily impact+4 | Sarah Glass | n-Lorem Foundation | — | nano-rareDYRK1A+5 | Chemgenes | 51m 29s | ||
| 3/25/26 | induced pluripotent stem cellspersonalized medicine+3 | — | n-Lorem FoundationInduced Pluripotent Stem Cells | — | iPSCsstem cells+4 | — | 30m 16s | ||
| 3/4/26 | drug developmentrare diseases+4 | — | MIT Sloan School of ManagementMIT’s Laboratory for Financial Engineering+3 | — | nano-rare diseasesFDA draft guidance+4 | — | 43m 20s | ||
| 2/11/26 | reflectionscommunity+3 | — | n-Lorem | — | n-LoremStan Crooke+5 | — | 18m 13s | ||
| 2/4/26 | genomicsscientific breakthroughs+3 | — | n-Lorem FoundationCNBC Cures | — | genomicsrare diseases+5 | ChemGenes | 33m 10s | ||
| 1/14/26 | nano-rare diseasesdrug safety+3 | — | n-Lorem FoundationData/Drug Safety Monitoring Board+1 | — | nano-rareASO+3 | — | 30m 38s | ||
| 12/17/25 | nano-rare diseasespatient stories+4 | — | n-Lorem Foundation | — | nano-rarepatient colloquium+4 | — | 46m 39s | ||
| 12/3/25 | n-LoremBiogen+3 | Natacha Gassenbach | Biogenn-Lorem | — | n-LoremBiogen+3 | — | 24m 47s |
Showing 16 of 16
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Patient Empowerment Program: A Rare Disease Podcast
Peaked at #94 in Brazil, currently #94 in Brazil.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Brazil | — | #94 | #94 | — |
| Japan | — | #103 | #103 | — |
| HK | — | #115 | #115 | — |
| Australia | — | #176 | #176 | — |
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.